Skip to main content

Table 2 Genetic matching for the primary and secondary outcomes in the non-HFOV and HFOV groups

From: The impact of high frequency oscillatory ventilation on mortality in paediatric acute respiratory distress syndrome

 

Non-HFOV (n = 118)

HFOV (n = 118)

p value

 
   

McNemar’s test

OR (95%CI)

28-day mortality [n (%)]

20 (16.9)

38 (32.2)

0.01

2.3 (1.3, 4.4)

   

Kruskal-Wallis test

MD (95% CI)*

VFD (median [IQR])

4.0 [0.0, 17.8]

4.0 [0.0, 16.0]

0.29

−1.3 (−3.4, 0.9)

IFD (median [IQR])

4.0 [0.0, 15.8]

0.0 [0.0, 11.0]

0.03

−2.5 (−4.9, −0.5)

  1. Categorical variables are presented as counts (percentages), continuous variables are presented as median [IQR]
  2. HFOV high-frequency oscillatory ventilation, VFD 28-day ventilator-free days, IFD 28-day intensive care unit-free days, MD mean difference, OR odds ratio, 95% CI 95% confidence interval
  3. *VFD and IFD did not follow normal distribution; therefore, we performed non-parametric Kruskal-Wallis test to determine the group differences and calculated the p values. Note that we still provide calculations for MD and corresponding 95% CI for VFD and IFD (assuming normal distribution), but the value of MD and 95% CI are only rough references. They should NOT be taken as true estimates and these need to be interpreted with caution